Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors

BACKGROUND: Immune checkpoint inhibitors (ICI) have revolutionized the treatment of metastatic renal cell carcinoma (mRCC). Biomarkers for mRCC patients treated with ICI are limited, and body composition is underutilized in mRCC. We investigated the association between body composition and clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Martini, Dylan J., Olsen, T. Anders, Goyal, Subir, Liu, Yuan, Evans, Sean T., Magod, Benjamin, Brown, Jacqueline T., Yantorni, Lauren, Russler, Greta Anne, Caulfield, Sarah, Goldman, Jamie M., Nazha, Bassel, Kissick, Haydn T., Harris, Wayne B., Kucuk, Omer, Carthon, Bradley C., Master, Viraj A., Bilen, Mehmet Asim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299332/
https://www.ncbi.nlm.nih.gov/pubmed/34307176
http://dx.doi.org/10.3389/fonc.2021.707050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299332/
https://www.ncbi.nlm.nih.gov/pubmed/34307176
http://dx.doi.org/10.3389/fonc.2021.707050

Ejemplares similares